Adynxx
San Francisco
About Adynxx
Adynxx a biopharmaceutical company, develops pain management drugs. It offers AYX1, a drug candidate to prevent acute post-operative pain and its transition into chronic pain; and AYX therapeutic programs, including long-term relief treatments for mature chronic pain syndromes. The company was incorporated in 2007 and is based in San Francisco, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: Less than $1M
- Total funding: $23.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2017)
- Website: adynxxinc.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Pharmaceutical
Canonical: https://fsome.com/organization/adynxx-62016 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.